Clinical Trial

Quality of Life and Lymphedema After Surgical Treatment of Gynecological Malignancies

Completed
View on ClinicalTrials.gov →
Summary
This prospective clinical study evaluates the accuracy of the currently used planning target volume (PTV) safety margin of 0.5 cm for stereotactic body radiotherapy (SBRT) of lung tumors at the Institute of Oncology Ljubljana. The study will assess setup errors and intrafractional motion using cone beam CT (CBCT) imaging in patients treated on three linear accelerators and with two different immobilization systems (vacuum cushion and long thermoplastic mask). Based on the collected data, the study aims to determine whether the current PTV margin is adequate and whether the SBRT setup protocol could be optimized.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-06.
Trial Details
NCT Number NCT07407179
Lead Sponsor Institute of Oncology Ljubljana
Conditions Gynecologic Cancer
Enrollment 40 participants
Start Date 2022-06-01
Primary Completion 2022-12-31 (estimated)
Study Completion 2022-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-18